Autologous haematopoietic stem cell transplantation (AHSCT) in severe Crohn's Disease: a review on behalf of ECCO and EBMT KU Leuven
Despite the major recent progress in the treatment of Crohn's disease (CD), there is a subset of patients in whom the disease runs an aggressive course with progressive tissue damage requiring early and repeated surgical management. Increasing evidence supports sustained and profound improvement in gastrointestinal parameters and quality of life following high dose immunosuppressive therapy and autologous haematopoietic stem cell transplantation ...